Pantheon China Acquisition Corp.
Completed 2009-07-07- CIK 1367209
- PCQC
- IPO 2006-12-15
- $28.9M trust
- 93 filings
Successfully merged with China Cord Blood Services Corporation
- IPO Size
- $30M
- raised at the IPO
- Trust
- $28.9M
- as of 2009-03-31
- Current Status
- Completed
- from its latest filing
- IPO Year
- 2006
- year it listed
Filings, by quarter
93 filings over 39 quarters; violet bars carry a milestone
- 06 Q3: 2 filings
- 06 Q4: 16 filings
- 07 Q1: 6 filings
- 07 Q2: 3 filings
- 07 Q3: 3 filings
- 07 Q4: 3 filings
- 08 Q1: 10 filings
- 08 Q2: 3 filings
- 08 Q3: 1 filing
- 08 Q4: 27 filings
- 09 Q1: 8 filings
- 09 Q2: 6 filings
- 09 Q3: 4 filings
- 09 Q4: 0 filings
- 10 Q1: 0 filings
- 10 Q2: 0 filings
- 10 Q3: 0 filings
- 10 Q4: 0 filings
- 11 Q1: 0 filings
- 11 Q2: 0 filings
- 11 Q3: 0 filings
- 11 Q4: 0 filings
- 12 Q1: 0 filings
- 12 Q2: 0 filings
- 12 Q3: 0 filings
- 12 Q4: 0 filings
- 13 Q1: 0 filings
- 13 Q2: 0 filings
- 13 Q3: 0 filings
- 13 Q4: 0 filings
- 14 Q1: 0 filings
- 14 Q2: 0 filings
- 14 Q3: 0 filings
- 14 Q4: 0 filings
- 15 Q1: 0 filings
- 15 Q2: 0 filings
- 15 Q3: 0 filings
- 15 Q4: 0 filings
- 16 Q1: 1 filing
- S-1 filed 06 Q3
- IPO 06 Q4
- Definitive agreement 08 Q4
- Completed 09 Q3
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
About
Pantheon China Acquisition Corp. is a blank-check company seeking to acquire or obtain control of an operating business with principal operations in the People’s Republic of China. Its efforts are not limited to a particular industry and no specific transaction is under consideration.
Geographic Focus
People’s Republic of China
Key Information
As the filings state it
- IPO Date
- 2006-12-15
- Jurisdiction of Incorporation
- Delaware
- SIC
- 6770
- Completion Date
- 2009-07-07
- Merger Target
- China Cord Blood Services Corporation
- SPAC Ticker
- PCQC
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
The management includes private equity, investment banking, financial advisory, and corporate operating experience, including experience in China and investment management.